fda glp-1 compounding crackdown news The FDA's Continues: What to Know FDA steps up crackdown on

The only possible problem with taking too much B12 is that a tenuous link between certain cancers and B12 does exist

Mehmet Oz said in a statement

IGF-1 LR3s agonism is directed principally at IGF-1R, but this receptor ecosystem is part of why growth-factor signaling is difficult to isolate cleanly in a whole organism

However, the type of fiber matters significantly for IBS sufferers

GLP-1 Stomach Paralysis Lawsuits The new GLP-1 pulmonary aspiration warnings come as the manufacturers already face hundreds of Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits, each raising similar allegations that users and the medical community were not adequately warned about serious risks that may result from delayed gastric emptying caused by the medications